Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2238943
Reference Type
Journal Article
Title
Topical nitroglycerin: a promising treatment option for chondrodermatitis nodularis helicis
Author(s)
Flynn, V; Chisholm, C; Grimwood, R
Year
2011
Is Peer Reviewed?
Yes
Journal
Journal of the American Academy of Dermatology
ISSN:
0190-9622
EISSN:
1097-6787
Volume
65
Issue
3
Page Numbers
531-536
Language
English
PMID
21529999
DOI
10.1016/j.jaad.2010.06.012
Web of Science Id
WOS:000294142000005
Abstract
BACKGROUND:
Chondrodermatitis nodularis helicis (CNH) is a painful nodule that often interferes with sleep and occurs on the helix or antihelix of the ear in older patients. Although several case reports describe a variety of seemingly effective surgical and conservative treatment options, well-studied treatment modalities have varying efficacy rates and can often demonstrate disappointing results.
OBJECTIVES:
The purpose of this study was to evaluate the efficacy of 2% topical nitroglycerin for the treatment of CNH.
METHODS:
A retrospective chart review was performed in 12 patients given the diagnosis of CNH who received 2% topical nitroglycerin twice daily for therapy. Therapeutic efficacy was determined by identifying improvement in the appearance and symptomatology of the lesion.
RESULTS:
A total of 13 lesions in 12 patients were treated, with 12 (92%) lesions demonstrating improvement with the use of topical nitroglycerin. Eight of 13 (61.5%) CNH lesions developed complete clearance and resolution of symptoms, requiring no further treatment. Four of 13 (30.8%) lesions were found to have only symptomatic improvement, and these patients continued to use the ointment as needed. One of 12 (8.3%) patients found no benefit with the treatment but had also failed multiple other treatments modalities.
LIMITATIONS:
Limitations include the small number of patients treated and the retrospective nature of the study.
CONCLUSIONS:
Topical nitroglycerin demonstrated efficacy in treating both the symptoms and lesional appearance of CNH in a noninvasive manner, with an overall success rate that is comparable with other published methods.
Keywords
chondrodermatitis nodularis helicis; clinical cases; ear; nitroglycerin; noninvasive; treatment
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity